Meet
Haile Dagne

Haile Dagne supports clients on market access, product commercialization, and reimbursement strategy.

He applies his background in health policy to help pharmaceutical manufacturers optimize access to their products.

Prior to joining Avalere, Haile was a billing supervisor at Hogan Lovells US LLP, working on financial analysis and billing issues. He also worked on FCC regulatory law issues at Lukas, Nace, Gutierrez & Sachs LLP.

Haile received an MPP from American University and a BA in economics from Washington and Lee University. At American University, Haile published a paper in The Public Purpose on the effect of the ACA on Medicaid financing.

Authored Content


New research shows higher cost sharing for vaccines under Part D leads to fewer seniors getting vaccines. Immunization rates are higher for vaccines covered by Part D plans with lower cost sharing.

On June 14, Avalere experts came together with Cynthia Tudor, former Deputy Center Director of the Center for Medicare and Senior Advisor to Avalere, to discuss vaccine coverage and access challenges under Medicare.

A proposed shift of Part B drugs into Part D could affect patient access and increase the burden on providers.

Avalere experts discuss adult immunization rates in the United States and how the disparate coverage of vaccines under Medicare creates significant barriers to increasing adult immunization uptake.